Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 71 (PPIAP71) is a non-coding pseudogene located in the human genome and annotated in gene databases such as NCBI Gene and GeneCards[5][6]. Pseudogenes are generally derived from protein-coding genes but have lost their ability to encode functional proteins due to mutations or transcriptional defects. While some pseudogenes can generate regulatory RNAs or influence expression of their parental genes, no such function has been reported for PPIAP71 specifically. Therefore, PPIAP71 does not encode an active enzyme or protein, is not a therapeutic target, and has no current research or clinical relevance as a drug target, biomarker, or disease factor. The parental gene PPIA is a well-studied isomerase (also known as cyclophilin A), but PPIAP71 itself does not share these functions[1][5][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 71 (PPIAP71).